CY1112111T1 - Διαδερμικο παρασκευασμα για εξωτερικη χρηση που περιεχει μη στεροειδες αντιφλεγμονωδες/αναλγητικο μεσο - Google Patents
Διαδερμικο παρασκευασμα για εξωτερικη χρηση που περιεχει μη στεροειδες αντιφλεγμονωδες/αναλγητικο μεσοInfo
- Publication number
- CY1112111T1 CY1112111T1 CY20111101190T CY111101190T CY1112111T1 CY 1112111 T1 CY1112111 T1 CY 1112111T1 CY 20111101190 T CY20111101190 T CY 20111101190T CY 111101190 T CY111101190 T CY 111101190T CY 1112111 T1 CY1112111 T1 CY 1112111T1
- Authority
- CY
- Cyprus
- Prior art keywords
- external use
- interderative
- inflammatory
- preparation
- use containing
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 230000001900 immune effect Effects 0.000 abstract 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ένα διαδερμικό παρασκεύασμα για εξωτερική χρήση που περιέχει ένα φωτοευαίσθητο NSAID κι έναν παρεμποδιστή UV που έχει υψηλή ικανότητα για μετανάστευση στο δέρμα. Έτσι, καθίσταται δυνατό να εξασφαλιστεί, σε ένα διαδερμικό παρασκεύασμα για εξωτερική χρήση που περιέχει ένα NSAID, η αναστολή της έναρξης φωτο-επαγόμενων μη ανοσολογικών ή ανοσολογικών δερματικών συμπτωμάτων από το συστατικό που περιγράφεται παραπάνω.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005050991 | 2005-02-25 | ||
EP06714545A EP1872796B1 (en) | 2005-02-25 | 2006-02-24 | Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112111T1 true CY1112111T1 (el) | 2015-11-04 |
Family
ID=36927466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101190T CY1112111T1 (el) | 2005-02-25 | 2011-12-02 | Διαδερμικο παρασκευασμα για εξωτερικη χρηση που περιεχει μη στεροειδες αντιφλεγμονωδες/αναλγητικο μεσο |
Country Status (13)
Country | Link |
---|---|
US (2) | US20080317689A1 (el) |
EP (1) | EP1872796B1 (el) |
JP (1) | JP5075622B2 (el) |
KR (1) | KR101298183B1 (el) |
CY (1) | CY1112111T1 (el) |
DK (1) | DK1872796T3 (el) |
ES (1) | ES2370511T3 (el) |
HK (1) | HK1112719A1 (el) |
PL (1) | PL1872796T3 (el) |
PT (1) | PT1872796E (el) |
SI (1) | SI1872796T1 (el) |
TW (1) | TWI403333B (el) |
WO (1) | WO2006090833A1 (el) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5374365B2 (ja) * | 2007-04-23 | 2013-12-25 | 久光製薬株式会社 | 貼付剤 |
CN103974700B (zh) * | 2011-12-07 | 2015-12-09 | 久光制药株式会社 | 贴附剂 |
US8822537B2 (en) * | 2012-09-27 | 2014-09-02 | Achelios Therapeutics, Inc. | Topical ketoprofen composition |
EP2968652B1 (en) | 2013-03-13 | 2020-07-22 | Avery Dennison Corporation | Improving adhesive properties |
WO2015129808A1 (ja) | 2014-02-27 | 2015-09-03 | 久光製薬株式会社 | ケトプロフェン含有パップ剤 |
JP2023513668A (ja) | 2020-02-05 | 2023-04-03 | マレル・サーモン・アクティエセルスカブ | 箱からストラップを取り外すための装置、システム、および方法 |
CN113524933B (zh) * | 2021-08-09 | 2023-05-30 | 湖北金德包装有限公司 | 一种改性醇酸树脂的制备方法及其在油墨中的应用 |
CN113652117B (zh) * | 2021-09-07 | 2022-12-13 | 廊坊市安鼎新材料科技有限公司 | 一种环保油墨及其在印刷工艺方法中的应用 |
CN115322099B (zh) * | 2022-07-27 | 2024-04-02 | 五邑大学 | 萘普生-肉桂酸衍生物及其在制备治疗lps诱导炎症的药物中的应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2544180C2 (de) * | 1975-10-03 | 1984-02-23 | Merck Patent Gmbh, 6100 Darmstadt | Lichtschutzmittel für kosmetische Zwecke |
JPS5399316A (en) | 1977-02-04 | 1978-08-30 | Sanpo Seiyaku Kk | Stbilyzing method of leserpine preparation |
JPS5622711A (en) | 1979-08-01 | 1981-03-03 | Pola Chem Ind Inc | Cosmetic prevented from photooxidizing |
JPS60155111A (ja) * | 1983-10-20 | 1985-08-15 | Hisamitsu Pharmaceut Co Inc | 安定なケトプロフェン含有外用経皮製剤 |
DE69228313T2 (de) * | 1991-08-30 | 1999-09-23 | Hisamitsu Pharmaceutical Co | Entzündungshemmendes, analgetisches pflaster |
JP3661706B2 (ja) * | 1993-10-28 | 2005-06-22 | 三省製薬株式会社 | 皮膚外用剤 |
DE69535737T2 (de) * | 1994-09-16 | 2009-04-09 | Hisamitsu Pharmaceutical Co., Inc., Tosu-shi | Pflaster zur externen anwendung |
JPH09169658A (ja) | 1995-12-19 | 1997-06-30 | Pola Chem Ind Inc | 抗炎症皮膚外用剤 |
KR20010013377A (ko) * | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | 마일드한 잔류성 항균 조성물 |
US5989528A (en) * | 1998-07-30 | 1999-11-23 | The Procter & Gamble Company | Sunscreen compositions |
JP2000136122A (ja) | 1998-10-28 | 2000-05-16 | Kose Corp | 皮膚外用剤 |
US6967023B1 (en) * | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
EP1269999B1 (en) * | 2000-03-17 | 2013-05-01 | Hisamitsu Pharmaceutical Co. Inc. | Ultraviolet-shielding patch |
FR2818127B1 (fr) * | 2000-12-18 | 2004-03-12 | Oreal | Composition filtrante photostable contenant un filtre du type derive du dibenzoylmethane et un compose 4,4-diarylbutadiene |
TWI327074B (en) * | 2003-05-07 | 2010-07-11 | Hisamitsu Pharmaceutical Co | Ultra violet shielding patch |
TWI337086B (en) * | 2003-09-03 | 2011-02-11 | Hisamitsu Pharmaceutical Co | Transdermal formulation containing nonsteroidal antiinflammatory drug |
GB0322342D0 (en) * | 2003-09-23 | 2003-10-22 | Gamble Reed | Skin patch |
TWI341736B (en) * | 2003-12-26 | 2011-05-11 | Hisamitsu Pharmaceutical Co | Anti-infammatory adhesive preparations |
US7013835B2 (en) * | 2004-04-27 | 2006-03-21 | David Brokaski | Cat litter device |
TWI414320B (zh) * | 2004-05-13 | 2013-11-11 | Hisamitsu Pharmaceutical Co | 含有非類固醇系消炎鎮痛劑之外用經皮製劑 |
EP1767218B1 (en) * | 2004-06-15 | 2016-08-10 | Hisamitsu Pharmaceutical Co., Inc. | Antiinflammatory and analgesic preparation for external use |
-
2006
- 2006-02-24 DK DK06714545.8T patent/DK1872796T3/da active
- 2006-02-24 EP EP06714545A patent/EP1872796B1/en active Active
- 2006-02-24 SI SI200631165T patent/SI1872796T1/sl unknown
- 2006-02-24 TW TW095106563A patent/TWI403333B/zh active
- 2006-02-24 JP JP2007504809A patent/JP5075622B2/ja active Active
- 2006-02-24 ES ES06714545T patent/ES2370511T3/es active Active
- 2006-02-24 PT PT06714545T patent/PT1872796E/pt unknown
- 2006-02-24 KR KR1020077020791A patent/KR101298183B1/ko active IP Right Grant
- 2006-02-24 WO PCT/JP2006/303406 patent/WO2006090833A1/ja active Application Filing
- 2006-02-24 US US11/884,990 patent/US20080317689A1/en not_active Abandoned
- 2006-02-24 PL PL06714545T patent/PL1872796T3/pl unknown
-
2008
- 2008-02-15 HK HK08101695.8A patent/HK1112719A1/xx unknown
-
2010
- 2010-04-29 US US12/769,870 patent/US20100311700A1/en not_active Abandoned
-
2011
- 2011-12-02 CY CY20111101190T patent/CY1112111T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1872796A1 (en) | 2008-01-02 |
KR20070104933A (ko) | 2007-10-29 |
KR101298183B1 (ko) | 2013-08-20 |
TW200640491A (en) | 2006-12-01 |
US20100311700A1 (en) | 2010-12-09 |
JP5075622B2 (ja) | 2012-11-21 |
DK1872796T3 (da) | 2011-10-17 |
PL1872796T3 (pl) | 2012-01-31 |
ES2370511T3 (es) | 2011-12-19 |
SI1872796T1 (sl) | 2011-12-30 |
US20080317689A1 (en) | 2008-12-25 |
EP1872796B1 (en) | 2011-09-21 |
PT1872796E (pt) | 2011-11-03 |
TWI403333B (zh) | 2013-08-01 |
EP1872796A4 (en) | 2009-08-26 |
WO2006090833A1 (ja) | 2006-08-31 |
JPWO2006090833A1 (ja) | 2008-07-24 |
HK1112719A1 (en) | 2008-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112111T1 (el) | Διαδερμικο παρασκευασμα για εξωτερικη χρηση που περιεχει μη στεροειδες αντιφλεγμονωδες/αναλγητικο μεσο | |
NO20170633A1 (no) | Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff . | |
CY2018018I2 (el) | Θεραπεια του οικογενους μεσογειακου πυρετου με αντι-il-1b αντισωματα | |
CR20160206A (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5 | |
EA200701771A1 (ru) | Низкомолекулярные ингибиторы mdm2 и их применение | |
CR20150054A (es) | Anticuerpos anti-cxcr5 humanizados derivados de los mismos y su uso | |
AR051925A1 (es) | Anticuerpos anti-ox4ol | |
CL2008001656A1 (es) | Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene. | |
CL2007001325A1 (es) | Compuestos derivados de biciclos, inhibidores de cept; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hiperlipidemia, arterioesclerosis, entre otras enfermedades. | |
DK1771178T3 (da) | Anvendelse af K-252A og kinaseinhibitorer til forebyggelse eller behandling af HMGB1-assocuerede patologiske tilstande | |
NO20073396L (no) | Farmasoytiske kombinasjoner av en angiotensinreceptorantagonist og en NEP-inhibitor | |
NO20081636L (no) | FAP - inhibitorer | |
DK1933821T3 (da) | Halevarianter af redox-aktive terapeutika til behandling af mitokondriesygdomme og andre tilstande og modulation af energibiomarkører | |
NO20075068L (no) | Lipocalinprotein | |
CL2010001483A1 (es) | Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune. | |
NO20083989L (no) | Spektroskop og fremgangsmate for a utfore spektroskopi | |
AR054474A1 (es) | Formulacion de anticuerpos estables | |
CL2004000416A1 (es) | Compuestos heterociclicos nitrogenados; composicion farmaceutica; y uso del compuesto para tratar o prevenir una condicion mediada por p38, que consiste en una enfermedad inflamatoria, autoinmune, virosica o neurodegenerativa. | |
EA200800172A1 (ru) | 2,4-диаминопиримидины как ингибиторы aurora | |
DE60232054D1 (de) | Jährlicher Kalendermechanismus für Uhrwerk | |
BRPI0515079A (pt) | marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados | |
EA202191806A1 (ru) | Антитело против человеческого il-4ra и его применение | |
CY1114735T1 (el) | Θεραπευτικες συνθεσεις οι οποιες περιεχουν εναν ειδικο ανταγωνιστη του υποδοχεα της ενδοθηλινης και εναν αναστολεα της pde5 | |
DK1856063T3 (da) | 5-phenyl-pentansyrederivater som matrix- metalloproteinaseinhibitorer til behandlingen af astma og andre sygdomme | |
CL2004001473A1 (es) | Procedimiento para producir neuronas desde celulas mesenquimatosas no diferenciadas y composicion que las contiene. |